FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065439 [Registered on: 09/04/2024] Trial Registered Prospectively
Last Modified On: 09/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Radiation Therapy 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Study of Medicated Oil and Phototherapy in Management of Skin Disease (Vitiligo) Shvitra. 
Scientific Title of Study   A Comparative Clinical Trial To Assess the Effect of Kushthrakshas tail and Phototherapy in Shvitra with special reference to Bhrajak Pitta 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sonali Rawat 
Designation  M D Scholar 
Affiliation  National Institute of Ayurveda 
Address  Department of kriya Sharir Room No 218 National Institute of Ayurveda Madhav Vilas Palace Jorawar Singh Gate Amer Road JAIPUR 302002 RAJASTHAN INDIA

Jaipur
RAJASTHAN
302002
India 
Phone  7055962744  
Fax    
Email  sonali.rawat.rs@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Chhaju Ram Yadav 
Designation  Professor 
Affiliation  National Institute of Ayurveda 
Address  Department of Kriya Sharir Room no 218 National Institute of Ayurveda Madhav Vilas Palace Jorawar Singh Gate Amer Road JAIPUR 302002 RAJASTHAN INDIA

Jaipur
RAJASTHAN
302002
India 
Phone  9460866101  
Fax    
Email  dr.yadavcr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rashmi Prakash Gurao  
Designation  Assistant Professor 
Affiliation  National Institute of Ayurveda 
Address  Department of Kriya Sharir Room no 218 National Institute of Ayurveda Madhav Vilas Palace Jorawar Singh Gate Amer Road JAIPUR 302002 RAJASTHAN INDIA

Jaipur
RAJASTHAN
302002
India 
Phone  9284142677  
Fax    
Email  drrashmigurao@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Ayurveda Deemed to be university Jorawar Singh Gate Jaipur 302002 
 
Primary Sponsor  
Name  National Institute of Ayurveda 
Address  Madhav Vilas Palace Jorawar Singh Gate Amer Road JAIPUR 302002 RAJASTHAN INDIA 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NOT APPLICABLE  NOT APPLICABLE 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sonali Rawat  National Institute of Ayurveda Jaipur  Department of Kriya Sharir OPD No 3 National Institute of Ayurveda Hospital Jaipur Rajasthan
Jaipur
RAJASTHAN 
7055962744

sonali.rawat.rs@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L80||Vitiligo. Ayurveda Condition: SVITRAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Kustharakshas tail, Reference: Bharat Bhaisagya Ratnakar, Route: Topical, Dosage Form: Taila, Dose: 30(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: No, Additional Information: Taila should be given as per patient disease condition
2Comparator Arm (Non Ayurveda)-Phototherapy The affected part will be treated with narrowband UVB monotherapy with a wavelength of 311 nanometers for about 20 minutes The patient will be advised to refrain from extreme sun exposure & use of cosmetics 2 sessions per week over a period of 12 weeks will be conducted
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 Subjects of either sex aged between 18 60 years
2 Subjects with diagnosed case of Shvitra 
 
ExclusionCriteria 
Details  1 Kco chronic systemic diseases Sexually Transmitted Diseases uncontrolled Diabetes
Mellitus Hypertension Blood Disorders or any organ failure
2 Contraindications of Phototherapy like Kco skin allergies photosensitive disorder
pregnancy breastfeeding women SLE etc
3 Taking any other medication for the same illness
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
PRIMARY OUTCOME
Change in the grade of VASI Vitiligo Area Severity Index score of Vitiligo
 
90 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Change in classical signs and symptoms like vaivarnya,suptata,atti chirouthitha,
sfutata etc. 
15 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="50" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/10/2024 
Date of Study Completion (India) 03/10/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
All the demographic and clinical data is presented and analysed in this section. Tabulated and Graphs of all observed data regarding of diseases, subjective parameters inserted. All the observations pertaining to the clinical study have been recorded and mentioned here Results of various intragroup and intergroup observations on criteria of assessment with respect to different statistical tests have been assessed, tabulated and analysed.

 Based on the observation done and results obtained, a logical discussion has been carried out of demographic results, objective and subjective criteria, results, mode of action of used drugs in clinical trial.

In conclusion, this dissertation presents a comprehensive analysis of fruits based on a clinical study. While the research findings have provided valuable insights, it is important to acknowledge the limitations of the study. Further investigations are warranted to delve deeper into specific aspects that require more exploration. The broader scope for future studies should focus on expanding the sample size, considering longer-term effects, and incorporating diverse methodologies to enhance our understanding of fruits and their impact on health. Overall, this dissertation serves as a foundation for future research in this area, shedding light on the significance of fruits in promoting well-being and offering a promising avenue for continued scientific inquiry. 

 
 
Close